MarketsandMarkets™ provides quantified B2B research on 30,000 high-growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently, we offer services to 7500 customers worldwide, including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their pain-points around revenue decisions.
Our 850 fulltime analysts and SMEs at MarketsandMarkets™ are tracking global high-growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, Avoid, and Defend" strategies, and identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ is now coming up with 1,500 MicroQuadrants (positioning top players across leaders, emerging companies, innovators, and strategic players) annually in high-growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
CN1699 is a B2B media platform, working closely with well-known health care media, associations, and conference organizers and in global. We distribute news of the media to support the medical needs package. These include trade, hospital investment, bidding, and advertising. The mode of cooperation is to make trade rely on the media to seek new and extensive needs and markets.
CN1699 link is a multi-actor of supply chains in form of media to create a global alliance for health care sharing information. The purpose is to ultimately promote multi-party cooperation in the global medical industry. CN1699 is also striving to complete trade support for long tail products and let more people enjoy fair medical care.
The mode of cooperation with CN1699 is to make trade rely on the media to seek new and extensive needs and markets. Let professional people share high-quality contents to push the industry to move on.
The aim of WIF is to promote and encourage the advancement of scientific knowledge and research in all aspects of immunology, infectious diseases and vaccines. To promote the exchange and dissemination of this knowledge across the world through meetings, publications and the media. It has close links with all regional national and international societies and associations.